Literature DB >> 3565039

Orosomucoid as one of the serum components contributing to normal capillary permselectivity in rat skeletal muscle.

B Haraldsson, B Rippe.   

Abstract

The effects of human serum orosomucoid (normal serum concentration 0.7-1.0 g l-1) on capillary permeability were investigated in 12 isolated maximally vasodilated rat hindquarters perfused with bovine serum albumin (50 g l-1) in modified Tyrode. Measurements were made of capillary filtration coefficient (CFC), permeability surface area product (PS) for vitamin B12 and isogravimetric clearance of radiolabelled albumin (Cl alb). The results were compared with those obtained using perfusates without addition of orosomucoid ('albumin group') or perfusates containing horse serum ('serum group'). Clearance of albumin was almost four-fold higher in the albumin than in the serum group, 0.0895 +/- 0.0066 (n = 12) and 0.0252 +/- 0.016 ml min-1 per 100 g (n = 18), respectively, while intermediate Cl alb values were obtained with human orosomucoid in the perfusate (greater than 0.1 g l-1), 0.0436 +/- 0.0034 ml min-1 per 100 g) (n = 8). These changes in Cl alb were not accompanied by any differences in CFC or PS. We conclude that orosomucoid is one of the components in serum (besides albumin) needed for the maintenance of normal permselectivity of the capillary walls of rat skeletal muscle. Alternatively, human orosomucoid is structurally related to other substances exerting this 'serum effect'.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3565039     DOI: 10.1111/j.1748-1716.1987.tb08047.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  16 in total

1.  Plasma proteins modify the endothelial cell glycocalyx of frog mesenteric microvessels.

Authors:  R H Adamson; G Clough
Journal:  J Physiol       Date:  1992-01       Impact factor: 5.182

2.  Permeability of frog mesenteric capillaries after partial pronase digestion of the endothelial glycocalyx.

Authors:  R H Adamson
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

3.  Transcytosis of alpha1-acidic glycoprotein in the continuous microvascular endothelium.

Authors:  D Predescu; S Predescu; T McQuistan; G E Palade
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 4.  Capillary permeability and how it may change.

Authors:  C C Michel
Journal:  J Physiol       Date:  1988-10       Impact factor: 5.182

5.  Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation.

Authors:  Yun Sok Lee; Jin Woo Choi; Injae Hwang; Joo Won Lee; Jae Ho Lee; A Young Kim; Jin Young Huh; Young Jun Koh; Gou Young Koh; Hee Jung Son; Hiroaki Masuzaki; Kikuko Hotta; Assim A Alfadda; Jae Bum Kim
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

6.  α(1)-Acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: possible protection against hemolysis-induced oxidative stress.

Authors:  Hisakazu Komori; Hiroshi Watanabe; Tsuyoshi Shuto; Azusa Kodama; Hitoshi Maeda; Kenji Watanabe; Hirofumi Kai; Masaki Otagiri; Toru Maruyama
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

7.  Serum levels of some acute phase proteins in kidney and urinary tract urothelial cancers.

Authors:  M Pejovic; V Djordjevic; I Ignjatovic; T Stamenic; V Stefanovic
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

8.  α1-Acid glycoprotein induced effects in rat brain microvessel endothelial cells.

Authors:  Shuangling Zhang; Karen S Mark
Journal:  Microvasc Res       Date:  2012-05-25       Impact factor: 3.514

9.  Effects of proteins on the permeability of monolayers of cultured bovine arterial endothelium.

Authors:  M R Turner
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

10.  Effect of perfusate pH on reduction of quinidine capillary permeability by albumin in isolated perfused rat heart.

Authors:  D J Morgan; C L Xu
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.